Drug Target Review

OCTOBER 3, 2024

Overcoming traditional antibody generation limitations with recombinant technologies Antibodies remain essential tools in this ever-changing field for preclinical bioanalysis and drug monitoring through ligand-binding assays (LBAs). Adapted from Harth S et al. (8) 8) under a CC BY-NC-ND 4.0. 2018 Dec 5;11(1):178–90.

52

52

Drug Discovery World

JUNE 12, 2023

Those are the beginning of additional manufacturing, scale of chemistry pharmacokinetics, pharmacology assays, development bioanalytical assays, and then moving forward toxicology work to start the initial clinical trials.

Research 130

Research Clinical Trials Doctors Assay Development 130

Drug Discovery World

OCTOBER 13, 2022

Combining the company’s technology with intelligent software, the STAR enables reliable and safe liquid handling performance, which leads to trustworthy results and lower routine laboratory costs. .

Drugs 130

Drugs Cell Based Assays Science Assay Development 130

Drug Discovery World

FEBRUARY 15, 2023

Another widely available commercial model is the cell-line derived xenograft (CDX) 9 that involves inoculation of fast-growing tumour cell lines into immunodeficient mice for various applications including pharmacokinetics, efficacy of cell killing, and studying tumour metastasis by in vivo imaging. Biochim Biophys Acta Rev Cancer.

Research 130

Research Therapies Immune Response Clinical Trials 130